Anixa Biosciences Inc - ESG Rating & Company Profile powered by AI
Alternative companies in the rating peer group for Anixa Biosciences Inc are shown below. This report of Anixa Biosciences Inc leverages data points from across the web as well as from available documents by Anixa Biosciences Inc. Browse to the end of this page for potential risks for Anixa Biosciences Inc based on industry, location and marketcap.
Anixa Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.0; made up of an environmental score of 1.6, social score of 8.0 and governance score of 5.3.
5.0
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 999 | Xeris Pharmaceuticals Inc | 5.1 | High |
| 999 | Vascular Biogenics Ltd | 5.1 | High |
| 1047 | Anixa Biosciences Inc | 5.0 | High |
| 1047 | Amarin Corporation PLC | 5.0 | High |
| 1047 | Ainos Inc | 5.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Anixa Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Anixa Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Anixa Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Anixa Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Anixa Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Anixa Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Anixa Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Anixa Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Anixa Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Anixa Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Anixa Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Anixa Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Anixa Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Anixa Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Anixa Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Anixa Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Anixa Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Anixa Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.